Respiratory Infections News

Hypertonic saline nose drops shortened cold symptom duration in young children and decreased household transmission, according to findings presented at the European Respiratory Society International Congress in Vienna.

During their first season in use, respiratory syncytial virus vaccines reduced the risk for RSV-associated hospitalization by 75% among adults aged 60 years or older, according to a study.

The federal government will once again be distributing free at-home COVID-19 tests to households across the country starting next month, health officials announced Friday.

People with virally suppressed HIV who are hospitalized with community acquired pneumonia do not have a higher mortality risk than people without HIV, according to a study.

A quarter of adults with a refractory nontuberculous mycobacterial infection had culture conversion during a 48-week daily inhaled molgramostim treatment period, according to results published in Annals of the American Thoracic Society.

A dose of Pfizer’s respiratory syncytial virus vaccine was well tolerated and generated a strong immune response among adults aged 59 years or younger, the company announced in a press release.

Patients with tuberculosis who used tobacco faced a heightened risk for disease recurrence/relapse and death during treatment, according to a systematic review and meta-analysis published in CHEST.

There are several methods and tools clinicians can utilize to improve vaccine confidence and boost immunization rates as the respiratory virus season approaches, according to an expert panel.

A phase 2b study of OHB-607, an investigational drug for the prevention of bronchopulmonary dysplasia, is currently recruiting extremely premature infants, according to a press release from Chiesi Group.

Between initial presentation in the ED and hospital discharge, 56.7% of veterans experienced a change in their pneumonia diagnosis, according to results published in Annals of Internal Medicine.